1. Home
  2. THFF vs IVA Comparison

THFF vs IVA Comparison

Compare THFF & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THFF
  • IVA
  • Stock Information
  • Founded
  • THFF 1984
  • IVA 2011
  • Country
  • THFF United States
  • IVA France
  • Employees
  • THFF N/A
  • IVA N/A
  • Industry
  • THFF Major Banks
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • THFF Finance
  • IVA Health Care
  • Exchange
  • THFF Nasdaq
  • IVA Nasdaq
  • Market Cap
  • THFF 686.6M
  • IVA 769.0M
  • IPO Year
  • THFF N/A
  • IVA 2020
  • Fundamental
  • Price
  • THFF $56.22
  • IVA $5.27
  • Analyst Decision
  • THFF Buy
  • IVA Strong Buy
  • Analyst Count
  • THFF 3
  • IVA 7
  • Target Price
  • THFF $59.50
  • IVA $16.57
  • AVG Volume (30 Days)
  • THFF 69.6K
  • IVA 141.3K
  • Earning Date
  • THFF 10-24-2025
  • IVA 09-29-2025
  • Dividend Yield
  • THFF 3.74%
  • IVA N/A
  • EPS Growth
  • THFF 21.43
  • IVA N/A
  • EPS
  • THFF 5.24
  • IVA N/A
  • Revenue
  • THFF $230,446,000.00
  • IVA $19,929,536.00
  • Revenue This Year
  • THFF $30.73
  • IVA N/A
  • Revenue Next Year
  • THFF $2.82
  • IVA N/A
  • P/E Ratio
  • THFF $10.41
  • IVA N/A
  • Revenue Growth
  • THFF 19.59
  • IVA N/A
  • 52 Week Low
  • THFF $42.05
  • IVA $2.11
  • 52 Week High
  • THFF $63.04
  • IVA $7.25
  • Technical
  • Relative Strength Index (RSI)
  • THFF 48.66
  • IVA 68.19
  • Support Level
  • THFF $53.93
  • IVA $4.96
  • Resistance Level
  • THFF $55.72
  • IVA $5.34
  • Average True Range (ATR)
  • THFF 1.43
  • IVA 0.52
  • MACD
  • THFF 0.26
  • IVA 0.19
  • Stochastic Oscillator
  • THFF 73.36
  • IVA 93.36

About THFF First Financial Corporation Indiana

First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: